SCRG1, as a diagnostic marker of OA, may be significantly up-regulated by hsa-miR-363-3p in synovitis of OA, and co-regulate immune-related pathways through the interaction of related proteins, playing an important role in the occurrence and development of OA, which may be a new drug target. The gene discussed is SCRG1; the disease is synovitis.